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Figure S1
Figure S1. CREB phosphorylation at S133 is defective in CC2D1A mutant cells.
A and B, Western blots of S133 phosphorylation of CREB in response to LPS (1ug/ml) or R848 (1ug/ml)treatment in WT and mutant macrophage cells. C, WB of IкBα, MAP kinase phosphorylation (p38, ERK, JNK) in response to LPS treatment in WT and mutant macrophage cells. D, WB of S133 phosphorylation of CREB in response to forskolin (50uM) treatment in WT and CC2D1A mutant MEF cells (used in Figure 4A ). E and F, WB of S133 phosphorylation of CREB in response to forskolin or LPS treatment. WT MEF cells were cultured and treated with PKA inhibitor H89 (30uM) and then with forskolin or LPS. In all cases cells were collected, washed with PBS and lysed in 1x RIPA buffer with protease inhibitors. Twenty ug protein was loaded from each lysate for WB analyses. analyzed by immuno-fluorescence using an anti-Cc2d1a antibody and DAPI to stain nucleus.
Deacon microscopy was used for imaging.
